FDA Inspection
CRM Alabama LLCCRM Alabama LLC – FDA Inspection, Jul 25, 2024
Record Details
This FDA Inspection record concerns CRM Alabama LLC, with an inspection on July 25, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c3cac32a-bda3-4d5d-882a-078a7fce9587
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1245882
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of CRM Alabama LLC
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 19, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 4, 2018 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 10, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 23, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 22, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CRM Alabama LLC
- FDA Inspection 1168733 - 2022-04-19
- FDA Inspection 1054221 - 2018-06-04
- FDA Inspection 951056 - 2015-12-10
- FDA Inspection 859992 - 2013-12-23
- FDA Inspection 788044 - 2012-06-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.